- Home
- ASR vs CORT Comparison
ASR vs CORT Comparison
Compare ASR & CORT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ASR
- CORT
- Stock Information
- Founded
- ASR 1996
- CORT 1998
- Country
- ASR Mexico
- CORT United States
- Employees
- ASR N/A
- CORT N/A
- Industry
- ASR Aerospace
- CORT Biotechnology: Pharmaceutical Preparations
- Sector
- ASR Consumer Discretionary
- CORT Health Care
- Exchange
- ASR Nasdaq
- CORT Nasdaq
- Market Cap
- ASR 7.9B
- CORT 7.1B
- IPO Year
- ASR 2000
- CORT N/A
- Fundamental
- Price
- ASR $289.22
- CORT $62.24
- Analyst Decision
- ASR Hold
- CORT Strong Buy
- Analyst Count
- ASR 1
- CORT 4
- Target Price
- ASR $310.00
- CORT $143.25
- AVG Volume (30 Days)
- ASR 62.8K
- CORT 2.5M
- Earning Date
- ASR 04-29-2025
- CORT 04-30-2025
- Dividend Yield
- ASR 4.16%
- CORT N/A
- EPS Growth
- ASR 32.81
- CORT 30.85
- EPS
- ASR 2.17
- CORT 1.23
- Revenue
- ASR $1,503,680,250.00
- CORT $675,040,000.00
- Revenue This Year
- ASR $16.40
- CORT $36.81
- Revenue Next Year
- ASR $10.07
- CORT $32.00
- P/E Ratio
- ASR $13.14
- CORT $50.60
- Revenue Growth
- ASR 21.34
- CORT 39.94
- 52 Week Low
- ASR $248.88
- CORT $20.84
- 52 Week High
- ASR $357.90
- CORT $117.33
- Technical
- Relative Strength Index (RSI)
- ASR 57.72
- CORT 45.43
- Support Level
- ASR $275.51
- CORT $65.07
- Resistance Level
- ASR $287.08
- CORT $71.15
- Average True Range (ATR)
- ASR 12.08
- CORT 8.92
- MACD
- ASR 1.47
- CORT -1.67
- Stochastic Oscillator
- ASR 90.71
- CORT 0.54
About ASR Grupo Aeroportuario del Sureste S.A. de C.V.
Grupo Aeroportuario del Sureste SAB de CV operates airports in southeast Mexico. The company's segments include Cancun; Aerostar; Airplan; Merida; Villahermosa; Holding and Services and other. It generates maximum revenue from the Cancun segment.
About CORT Corcept Therapeutics Incorporated
Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol.